Bahrain allows vaccination for ages 12 to 17 – BNA

By Syndicated Content
May 18, 2021 | 3:25 PM
CAIRO (Reuters) – Bahrain will vaccinate adolescents aged 12-17 with two doses of the Pfizer-BioNTech vaccine, state news agency BNA said, citing the country’s National Medical Task Force for Combatting the Coronavirus (COVID-19) on Tuesday.
The decision by the health ministry’s vaccination committee followed recommendations by the World Health Organization’s Strategic Advisory Group of Experts on Immunization and the United States’ Center for Disease Control, BNA added.
A guardian must grant approval and be present during the vaccination, BNA reported.
Bahrain had authorized six types of vaccines, by China’s Sinopharm, Pfizer Inc and BioNTech SE, AstraZeneca Plc, Johnson & Johnson, and Russia’s Sputnik and Sputnik-Light.

Related Keywords

Cairo ,Al Qahirah ,Egypt ,World Health Organization ,Bahrain ,Omar Fahmy ,Richard Chang ,Nayera Abdallah ,Pfizer ,Pfizer Inc ,United State Center ,Johnson ,Astrazeneca Plc ,Reuters ,National Medical Taskforce ,Strategic Advisory Group ,Disease Control ,கெய்ரோ ,எகிப்து ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,பஹ்ரைன் ,ஓமர் பஹ்மி ,ரிச்சர்ட் சாங் ,ஃபைசர் ,ஃபைசர் இன்க் ,ஒன்றுபட்டது நிலை மையம் ,ஜான்சன் ,ராய்ட்டர்ஸ் ,நோய் கட்டுப்பாடு ,